Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 50 Records) |
| Query Trace: Leukemia and Mpl[original query] |
|---|
| Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients. American journal of hematology 2017 Nov . Tefferi Ayalew, Nicolosi Maura, Mudireddy Mythri, Szuber Natasha, Finke Christy M, Lasho Terra L, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Gangat Naseema, Mannarelli Carmela, Fanelli Tiziana, Guglielmelli Paola, Vannucchi Alessandro |
| Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors. Medical oncology (Northwood, London, England) 2018 Aug 35 (9): 119. Helbig Grzego |
| ASXL1 mutations in Chinese patients with essential thrombocythemia. Experimental and therapeutic medicine 2018 May 15 (5): 4149-4156. Nie Yan-Bo, Sun Meng, He Colin K, Ju Man-Kai, Zhou Fu-Ling, Wu San-Yun, Zhou Yi, Liu Li, Shen Hui, Huang Ting-Ting, Liu Pan, Xu Ying, Shao Liang, Zuo Xue-L |
| [Spectrum of somatic mutations and their prognostic significance in adult patients with B cell acute lymphoblastic leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2018 Feb 39 (2): 98-104. Feng J, Gong X Y, Jia Y J, Liu K Q, Li Y, Dong X B, Fang Q Y, Ru K, Li Q H, Wang H J, Zhao X L, Jia Y N, Song Y, Tian Z, Wang M, Tang K J, Wang J X, Mi Y |
| Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center. Neoplasma 2018 65 (2): 296-303. Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M, Papajik |
| Selected Parameters of Angiogenesis and the JAK2, CALR, and MPL Mutations in Patients With Essential Thrombocythemia. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2018 Jan 1076029617740222. Gadomska Gra?yna, Bartoszewska-Kubiak Alicja, Boinska Joanna, Matiakowska Karolina, Zio?kowska Katarzyna, Haus Olga, Ro?? Danu |
| The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosis. American journal of hematology 2019 Mar 94 (3): 299-305. Tefferi Ayalew, Lasho Terra L, Mudireddy Mythri, Finke Christy M, Hanson Curtis A, Ketterling Rhett P, Gangat Naseema, Pardanani Anime |
| Prevalence of MPL (W515K/L) Mutations in Patients with Negative-JAK2 (V617F) Myeloproliferative Neoplasm in North-East of Iran. Iranian journal of pathology 2018 13 (4): 397-402. Shams Seyyede Fatemeh, Ayatollahi Hossein, Sadeghian Mohammad Hadi, Afzalaghaee Monavar, Shakeri Sepideh, Yazdandoust Ehsan, Sheikhi Maryam, Amini Nafiseh, Bakhshi Samane, Bahrami Afsa |
| Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia. Leukemia research reports 2019 12 12 100185. Geissler Klaus, Jäger Eva, Gurbisz Micha |
| WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis. Blood cells, molecules & diseases 2019 1 75 35-40. Cottin Laurane, Riou Jérémie, Boyer Françoise, Bouvier Anne, Zannetti Alain, Blouet Anaïse, Truchan-Graczyk Matgorzata, Jouanneau-Courville Rébecca, Beucher Annaëlle, Ribourtout Bénédicte, Orvain Corentin, Hunault-Berger Mathilde, Blanchet Odile, Ugo Valérie, Luque Paz Dami |
| JAK2, CALR, and MPL Mutations in Egyptian Patients With Classic Philadelphia-negative Myeloproliferative Neoplasms. Clinical lymphoma, myeloma & leukemia 2020 6 20 (10): e645-e651. Soliman Eman A, El-Ghlban Samah, El-Aziz Sherin Abd, Abdelaleem Abdelaleem, Shamaa Sameh, Abdel-Ghaffar Hass |
| Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms. Leukemia 2020 12 35 (8): 2371-2381. Todisco Gabriele, Creignou Maria, Gallì Anna, Guglielmelli Paola, Rumi Elisa, Roncador Marco, Rizzo Ettore, Nannya Yasuhito, Pietra Daniela, Elena Chiara, Bono Elisa, Molteni Elisabetta, Rosti Vittorio, Catricalá Silvia, Sarchi Martina, Dimitriou Marios, Ungerstedt Johanna, Vannucchi Alessandro Maria, Hellström-Lindberg Eva, Ogawa Seishi, Cazzola Mario, Malcovati Lu |
| Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN). International journal of environmental research and public health 2021 Jul 18 (14): . Zulkeflee Razan Hayati, Zulkafli Zefarina, Johan Muhammad Farid, Husin Azlan, Islam Md Asiful, Hassan Rosli |
| Clinical and Molecular Attributes of Patients With BCR/ABL1-negative Myeloproliferative Neoplasms in India: Real-world Data and Challenges. Clinical lymphoma, myeloma & leukemia 2021 3 21 (6): e569-e578. Singh Suvir, Kaur Komalpreet, Paul Davinder, Jain Kunal, Singh Jagdeep, Narang Vikram, Garg Bhavna, Sood Neena, Dhillon Barjinderj |
An Asian-specific MPL genetic variant alters JAK-STAT signaling and influences platelet count in the population.
Human molecular genetics 2021 Mar . Sun Pengfei, Zhou Wei, Fu Yi, Cheung Chloe Y Y, Dong Yujun, Yang Min-Lee, Zhang He, Jia Jia, Huo Yong, Willer Cristen J, Chen Y Eugene, Tang Clara S, Tse Hung-Fat, Lam Karen S L, Gao Wei, Xu Ming, Yu Haiyi, Sham Pak Chung, Zhang Yan, Ganesh Santhi |
| Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? Mediterranean journal of hematology and infectious diseases 2021 11 13 (1): e2021062. Sora Federica, Chiusolo Patrizia, Autore Francesco, Giammarco Sabrina, Laurenti Luca, Innocenti Idanna, Metafuni Elisabetta, Galli Eugenio, Bacigalupo Andrea, Sica Simo |
| Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 Jun . Tashakori Mehrnoosh, Khoury Joseph D, Routbort Mark J, Patel Keyur P, Wang Sa A, Ok Chi Young, El-Hussein Siba, Kanagal-Shamanna Rashmi, Luthra Rajyalakshmi, Hu Shimin, Lin Pei, Pemmaraju Naveen, Bose Prithviraj, Verstovsek Srdan, Bueso-Ramos Carlos E, Medeiros L Jeffrey, Loghavi San |
| Comparison of Clinical and Hematological Parameters of Janus Kinase 2, Calreticulin or Myeloproliferative Leukemia Virus Oncogene Mutant Essential Thrombocythemia and Triple-Negative Essential Thrombocythemia. Cureus 2022 4 14 (3): e23171. Y?ld?z Jale, Batgi Hikmettull |
| Lab tests for MPN. International review of cell and molecular biology 2022 2 366 187-220. Moncada Alice, Pancrazzi Alessand |
| Landscape and clinical impact of NOTCH mutations in newly diagnosed acute myeloid leukemia. Cancer 2022 11 129 (2): 245-254. Han Haohao, Yao Yifang, Wang Hong, Zhou Meng, Zhang Ziyan, Xu Xiaoyan, Qi Jiaqian, Liu Yuejun, Wu Depei, Han Y |
| Comparison of Clinical and Molecular Features Between Patients With Essential Thrombocythemia and Early/Prefibrotic Primary Myelofibrosis Presenting With Thrombocytosis in Taiwan. American journal of clinical pathology 2023 3 . Kuo Ming-Chung, Chuang Wen-Yu, Chang Hung, Lin Tung-Huei, Wu Jin-Hou, Lin Tung-Liang, Ou Che-Wei, Hung Yu-Shin, Huang Ting-Yu, Huang Ying-Jung, Wang Po-Nan, Shih Lee-Yu |
| Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
| STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 2023 12 . Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jia |
| Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 2023 1 15 (2): . Sargas Claudia, Ayala Rosa, Larráyoz María José, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao-Sieyro Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan Miguel, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Domínguez Juan Manuel, García-Boyero Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María José, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María José, García-Sanz Ramón, Pérez-Simón José Antonio, Gómez-Casares María Teresa, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau, On Behalf Of Pethema Grou |
| Allogeneic hematopoietic cell transplantation for myelofibrosis aged 70 years or older: a study from the German Registry for Stem Cell Transplantation. Transplantation and cellular therapy 2024 8 . Nico Gagelmann, Claudia Schuh, Robert Zeiser, Matthias Stelljes, Wolfgang Bethge, Gerald Wulf, Daniel Teschner, Stefan Klein, Eva Wagner-Drouet, Edgar Jost, Peter Dreger, Sarah Flossdorf, Nicolaus Krög |
| Clonal evolution process from essential thrombocythemia to acute myeloid leukemia in the original patient from whom the CALR-mutated Marimo cell line was established. Nagoya journal of medical science 2024 7 86 (2): 326-332. Yoko Ushijima, Yuichi Ishikawa, Takahiro Nishiyama, Naomi Kawashima, Takashi Kanamori, Masashi Sanada, Hitoshi Kiy |
| A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-related. International journal of laboratory hematology 2024 4 . Dong Chen, Julia Geyer, Adam Bagg, Robert Hasserjian, Olga K Weinbe |
| Abdominal venous thromboses: detection of the JAK2 p.V617F mutation by next-generation ultradeep sequencing-A prevalence study of patients in Mecklenburg-West Pomerania (2017-2021). Frontiers in medicine 2024 1 10 1344769. Larissa Henze, Luise Grunwald, Sabine Felser, Maria Witte, Christina Grosse-Thie, Catrin Roolf, Hugo Murua Escobar, Christian Junghan |
| One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 2024 1 14 (1): 11. Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Teffe |
| One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 2024 1 14 (1): 10. Giuseppe G Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro M Vannucchi, Paola Guglielmel |
- Page last reviewed:Feb 1, 2024
- Content source: